Vor Biopharma (VOR) Preferred Dividend Payments (2020 - 2021)
Vor Biopharma (VOR) reported Preferred Dividend Payments of $1.2 million for Q1 2021, up 71.75% year-over-year from $715000.0 in Q1 2020, and down 43.41% on a QoQ basis from $2.2 million in Q4 2020.
Vor Biopharma (VOR) has 2 years of Preferred Dividend Payments data on file, last reported at $1.2 million in Q1 2021.
- Quarterly Preferred Dividend Payments rose 71.75% year-over-year to $1.2 million in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $1.2 million (down 79.27% YoY) and the FY2021 annual result came in at $1.2 million, down 79.27% from the prior year.
- Preferred Dividend Payments slipped to $1.2 million in Q1 2021 per VOR's latest filing, from $2.2 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $2.2 million in Q3 2020 and bottomed at $715000.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vor Biopharma | 628.83 Mn | 628.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1.23 Mn |
| Dec 31, 2020 | 2.17 Mn |
| Sep 30, 2020 | 2.19 Mn |
| Jun 30, 2020 | 855,000.00 |
| Mar 31, 2020 | 715,000.00 |